与非COPD患者相比,稳定慢性阻塞性肺病 (COPD) 患者的骨肌肉损伤
Zhen-Yun Wu1, Xiang-Min Lu2, Rui Liu1
1Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
概括
骨肌缩在慢性阻塞性肺病 (COPD) 患者中更为普遍. 牛犊周长可以帮助检测肌肉损伤,特别是医院以外的医疗保健提供者.
科学领域:
- 肺部医学 肺部医学
- 骨肌肉生理学 骨肌肉生理学
- 身体组成分析 身体成分分析
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种渐进的肺病,通常与全身表现有关.
- 骨肌功能障碍,包括缩,是COPD患者显著的并发症,影响生活质量和预后.
- 了解导致COPD骨肌缩的因素对于制定有效的管理策略至关重要.
研究的目的:
- 为了研究稳定的COPD患者和健康对照人群之间的骨肌肉缩的差异.
- 为了确定与COPD患者骨肌肉质量减少相关的因素.
主要方法:
- 一项涉及123名稳定的COPD患者和60名健康对照者的比较研究,来自中国苏州市.
- 评估包括螺旋计,功能性运动能力 (6分钟步行距离),身体组成 (无脂肪质量指数 - FFMI) 和手握强度 (HGS).
- 采用多变量回归分析来确定与FFMI相关的因素.
主要成果:
- 与对照组相比,COPD患者的无脂肪体重 (FFM),FFMI和6分钟步行距离 (6MWD) 显著降低.
- 在COPD患者中,手握强度 (HGS) 也较低,接近统计学意义.
- 多变量分析显示,年龄,性别,BMI,FEV1%,以及小牛周长 (CC) 与FFMI有显著的关联.
结论:
- 骨肌肉质量的损伤在COPD患者中更为常见.
- 牛犊周长 (CC) 成为评估COPD患者肌肉损伤程度的潜在指标.
- 对医疗保健提供者来说,CC测量可能是一个实用的工具,特别是在非医院环境中,以检测COPD的肌肉缩.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K